Borders General Hospital is a district general hospital on the outskirts of Melrose, Scotland. It is managed by NHS Borders.

There are 328 beds in Borders General Hospital.

During the past decade, Borders General Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Borders General Hospital" #1 sponsor was "Celgene" with 2 trials, followed by "University of Edinburgh" with 2 trials sponsored, "Cardiff and Vale University Health Board" with 1 trials sponsored, "ETOP IBCSG Partners Foundation" with 1 trials sponsored and "Glasgow Caledonian University" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Borders General Hospital" #1 collaborator was "NHS Lothian" with 3 trials as a collaborator, "Cancer Research UK" with 2 trials as a collaborator, "University of Aberdeen" with 2 trials as a collaborator, "Arthritis Research UK" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Borders General Hospital" are "Breast Cancer" (3 trials), "Crohn Disease" (2 trials), "Acute Coronary Syndrome" (1 trials), "Breast Cancer Female" (1 trials) and "Breast Neoplasm" (1 trials). Many other conditions were trialed in "Borders General Hospital" in a lesser frequency.

Most popular intervention types in "Borders General Hospital" are "Drug" (9 trials), "Procedure" (5 trials), "Other" (3 trials), "Radiation" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "GED-0301" (2 trials), "Placebo" (2 trials), "A package of interventions" (1 trials), "Augmented autologous stem cell transplant (ASCT-aug)" (1 trials) and "Axillary lymph node dissection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Borders General Hospital" are 12 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Borders General Hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Borders General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Borders General Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".